This article is more than 5 years old. Information may no longer be current.

Visian Toric phakic IOL granted Canadian marketing approval

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

MONROVIA, Calif. — A toric posterior chamber phakic IOL has been granted marketing approval by Canadian authorities, the device’s maker said in a press release.

STAAR Surgical said its Visian Toric lens is “the first lens to be approved to correct both nearsightedness and astigmatism in a single procedure.”

The non-toric version of the lens, the Visian ICL, is approved for marketing in about 40 countries and has been implanted in 40,000 eyes worldwide, the STAAR press release said. The lens has not yet received marketing approval in the United States.